Clinical Studies 14.1 Overview of Clinical Trials TRULICITY has been studied in adults as monotherapy and in combination with metformin, sulfonylurea, metformin and sulfonylurea, metformin and thiazolidinedione, sodium-glucose co-transporter-2 inhibitors (SGLT2i) with or without metformin, basal insulin with or without metformin, and prandial insulin with or without metformin
Ambrish Mithal weighs in on who should take it, how it works, and why it's not a shortcut to health
Not a Quick Fix for Plateau: If youve plateaued on one medication, switching might help, but also consider: Have you reached a healthy weight for your body
GLP-3 (Reta) Research Applications GIP, GLP-1 and glucagon receptor binding and cAMP-accumulation assays in cells co-expressing the three receptors, where GLP-3 (Reta) is the standard reference triple agonist
The trial DXA data suggests structured resistance training partially blocks GLP-1 lean-mass loss